Contineum Therapeutics, Inc.(CTNM) - Prospectus(update)

As filed with the Securities and Exchange Commission on April 1, 2024. Table of Contents Registration No. 333-278003 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 CONTINEUM THERAPEUTICS, INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 27-1467257 (Primary Standard Industrial Classification Code Number) (I.R.S. Em ...